Kone

HEALTH CONCERNS

10/07/26 -"Non Pharma Health stocks have long been suffering. The sector has lost 39% ytd, not  helped by EssilorLuxottica’s -35% correction. EL’s connected smart glasses are no longer leading to moon chasing ..."

PDF page sample
Pages
74
Language
English
Published on
10/07/26
Download
You may also be interested by these reports :
17/07/26
Results aligned with revenue expectations, with a marginally improved operating profit. However, reported EBIT fell short due to recurring ...
17/07/26
GF delivered 5.7% organic growth in H1 2026, supported by strong momentum in Industry and Infrastructure, while margin conversion remained below ...
17/07/26
The company reported revenue and EBIT approximately 2% below expectations, though the shortfall appears immaterial. Order intake met forecasts, and ...
17/07/26
Georg Fischer reported its H1 2026 results, with Flow Solutions revenue slightly ahead of consensus (+3.2%), while comparable EBITDA and EBIT were ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO